BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. The BostonGene Tumor Portrait™ Test integrates genomic (WES) and transcriptomic (RNA-seq) analyses of tumors and the tumor microenvironment in the single report to reveal key drivers of each tumor.